Capillary leak syndrome future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [[1]]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S
Overview
Overview
The relationship between Capillary leak syndrome and post-episodic levels of monoclonal IgG are of interest and continue to be studied. In one out of five patients, a monoclonal IgG gammopathy has been found.
Future or Investigational therapies
Future or Investigational therapies
After an attack, various substances were measured in the body including products derived the coagulation pathway, complement pathway, bradykinin generation, prostaglandins and histamine metabolism. Although these products were all in within normal limits, affected individuals were continuously found to have a monoclonal IgG gammopathy. Studies continue to be done to understand the relationship between monoclonal IgG gammopathy and Capillary leak syndrome.[1]
References
References
- ↑ Atkinson JP, Waldmann TA, Stein SF, Gelfand JA, Macdonald WJ, Heck LW; et al. (1977). “Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature”. Medicine (Baltimore). 56 (3): 225–39. doi:10.1097/00005792-197705000-00004. PMID 870792.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH